(Added content) |
|||
| Line 27: | Line 27: | ||
*Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Many barriers impede the implementation of product substitution in tobacco harm reduction. These products have been subjected to regulatory bans and heavy taxation and are rejected by smokers and society based on misperceptions about nicotine, sensational media headlines and unsubstantiated fears of youth addiction. These barriers will need to be addressed if tobacco harm reduction is to make the maximum impact on the smoking endemic. | *Toxicological testing, population studies, clinical trials and randomized controlled trials demonstrate the potential reductions in exposures for smokers. Many barriers impede the implementation of product substitution in tobacco harm reduction. These products have been subjected to regulatory bans and heavy taxation and are rejected by smokers and society based on misperceptions about nicotine, sensational media headlines and unsubstantiated fears of youth addiction. These barriers will need to be addressed if tobacco harm reduction is to make the maximum impact on the smoking endemic. | ||
*Increasing taxes on reduced-risk products could function to deter smokers from switching to them. | *Increasing taxes on reduced-risk products could function to deter smokers from switching to them. | ||
*To reduce smoking and to save millions of lives, tobacco harm reduction in the form of cigarette substitution with low-risk products appears to be a promising path. These products, although not completely risk-free, offer an alternative to quit or die. In consideration of the available evidence, advice to tobacco smokers should include trying substitute products. The obvious fact so often overlooked is that smoking is rewarding and people like to do it. Giving smokers an alternative with efficient nicotine delivery means that they might prefer one of these products over cigarettes. | |||
<br> | |||
<br> | |||
===2019: [https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3503054 E-Cigarettes and Adult Smoking: Evidence from Minnesota]=== | ===2019: [https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3503054 E-Cigarettes and Adult Smoking: Evidence from Minnesota]=== | ||
edits